M&A

Audentes CEO exits as Astellas rebrands a gene therapy buyout
BioPharma Dive
Thu, 04/1/21 - 11:01 am
Astellas
Audentes
gene therapy
M&A
Astellas Gene Therapies
Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m
Pharmaceutical Business Review
Thu, 04/1/21 - 10:50 am
Takeda
OTC
M&A
Orifarm
Drugmaker Bausch to sell stake in Egypt's Amoun Pharma for $740 million
Reuters
Wed, 03/31/21 - 10:42 am
Bausch Health
Amoun
ADQ
M&A
Illumina Stock Tumbles As FTC Moves To Block $7.1 Billion Grail Acquisition
Investors Business Daily
Tue, 03/30/21 - 10:26 pm
Illumina
FTC
Grail
M&A
liquid biopsy
Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers
Fierce Biotech
Tue, 03/30/21 - 10:23 pm
Amgen
Rodeo Therapeutics
M&A
Why Roche's $1.8 Billion Acquisition of GenMark Is a Smart Move
Motley Fool
Wed, 03/24/21 - 10:01 am
Roche
GenMark
M&A
Fidia Farmaceutici acquires Sanofi’s anti-inflammatory drugs portfolio
Pharmaceutical Business Review
Wed, 03/24/21 - 10:00 am
Sanofi
Fidia Farmaceutici
M&A
anti-inflammatories
How Five Prime suitor Amgen battled multiple companies for the biotech—and won
Fierce Biotech
Fri, 03/19/21 - 10:48 am
Amgen
M&A
Five Prime Therapeutics
SEC
oncology
FTC eyes new approach to pharmaceutical mergers
The Hill
Tue, 03/16/21 - 10:45 pm
FTC
M&A
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
Tue, 03/16/21 - 11:04 am
AbbVie
Women's Health
Allergan
Humira
M&A
Merck wins priority review for rare carcinoma drug belzutifan, the centerpiece of $1B+ Peloton buyout
Endpoints
Tue, 03/16/21 - 10:54 am
Merck
Peloton Therapeutics
belzutifan
M&A
PT2977
renal cell carcinoma
priority review
FDA
After Acquiring Bayer Animal Health, Elanco Is Poised for Earnings Growth in 2021
Motley Fool
Tue, 03/16/21 - 10:51 am
animal health
Elanco Animal Health
M&A
Bayer Animal Health
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Endpoints
Mon, 03/15/21 - 10:50 am
Roche
Genentech
M&A
GenMark Diagnostics
diagnostics
Grifols reaches across the Atlantic and shells out $450M in a pair of M&A deals
MedCity News
Sun, 03/14/21 - 10:50 pm
Grifols
M&A
GigaGen
From partner to part of the family: Takeda pulls the trigger on Maverick buyout
Fierce Biotech
Tue, 03/9/21 - 10:32 am
Takeda
Maverick Therapeutics
M&A
T-cell engager
Boston Scientific’s next move
EP Vantage
Mon, 03/8/21 - 10:23 am
Boston Scientific
devices
M&A
Lumenis
Preventice
cardiology
Jazz CEO Bruce Cozadd campaigned for 6 months to buy GW Pharma. A 90% premium sealed the deal — along with $17.6M in ‘retention’ incentives
Endpoints
Sun, 03/7/21 - 01:33 pm
Jazz Pharmaceuticals
Pharma CEOs
Justin Glover
GW Pharma
M&A
Biotech Pandion's secret to moving a $65M Merck offer to a $1.9B done deal in a year? Just keep saying no
Fierce Biotech
Fri, 03/5/21 - 10:45 am
Pandion
Merck
M&A
March medtech merger madness
EP Vantage
Thu, 03/4/21 - 11:36 pm
devices
M&A
Boston Scientific
Lumenis
Asuragen
Bio-Techne
LivaNova
Amgen adds gastric cancer drug candidate in $1.9 billion Five Prime Therapeutics deal
Reuters
Thu, 03/4/21 - 10:29 am
Amgen
Five Prime Therapeutics
M&A
gastric cancer

Pages